术前VA-ECMO降低晚期结构性心脏病手术风险评分
结论认为ECMO可作为严重失代偿患者过渡到瓣膜或室间隔缺损手术的桥梁。
要点
- 心源性休克合并终末器官衰竭的高危结构性心脏病患者可考虑术前VA-ECMO支持。
- ECMO支持后血管活性药需求、肌酐、乳酸、pH及STS风险评分均显著改善。
- 本组所有手术患者存活出院,随访期间2例死亡、6例存活超过1年。
核心结论
- ECMO可作为严重失代偿结构性心脏病患者过渡到心脏瓣膜或室间隔缺损手术的桥梁。
- 通过恢复终末器官功能,ECMO可能使被认为无法手术的患者获得手术矫正机会或将抢救性手术转为择期手术。
研究设计与样本
- 患者平均STS死亡风险为24%±13%,术前接受外周VA-ECMO支持7±4天。
- 手术类型包括人工二尖瓣狭窄4例、乳头肌断裂4例、缺血性室间隔缺损3例、重度主动脉瓣狭窄1例。
主要发现
- 患者平均年龄61±8岁,合并急性肾衰竭11例、需正性肌力药10例、IABP 8例、严重酸中毒6例、需大剂量血管升压药8例、心脏骤停1例。
- ECMO支持后血管升压药需求、中心静脉压、肌酐、乳酸、pH、肺动脉高压、STS死亡风险及EuroSCORE II均显著改善。
- 1例ECMO期间因最初未知的缺氧性脑损伤撤除治疗,出院时无患者需要透析,并发症包括1例永久性卒中。
- 所有手术患者存活至出院,平均随访420天,2例分别于76天和230天死亡,6例存活超过1年。
临床怎么用
- 对心源性休克合并终末器官衰竭的高危结构性心脏病患者,可评估术前VA-ECMO支持以改善器官功能后再行手术。
- ECMO支持期间需监测神经系统并发症及终末器官恢复情况,以决定手术时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac surgery for structural heart disease has poor outcomes in the presence of cardiogenic shock or advanced heart failure. We applied venoarterial extracorporeal membrane oxygenation (ECMO) to restore end-organ function and resuscitate patients before high-risk cardiac operation. METHODS: Twelve patients with cardiogenic shock and end-organ failure were evaluated for cardiac surgery. The average Society of Thoracic Surgeons mortality risk was 24% ± 13%. Patients were peripherally cannulated on ECMO for 7 ± 4 days, before undergoing operation for prosthetic mitral stenosis (n = 4), ruptured papillary muscle (n = 4), ischemic ventricular septal defect (n = 3), or severe aortic stenosis (n = 1). RESULTS: Mean age was 61 ± 8 years. Comorbidities included acute renal failure (n = 11), inotrope requirement (n = 10), intraaortic balloon pump (n = 8), severe acidosis (n = 6), high-dose vasopressor requirement (n = 8), and cardiac arrest (n = 1). With ECMO support, vasopressor requirement, central venous pressure, creatinine, lactate, pH, pulmonary hypertension, and The Society of Thoracic Surgeons mortality risk and EuroSCORE (European System for Cardiac Operative Risk Evaluation) II all improved significantly. Care was withdrawn in 1 patient on ECMO with initially unknown anoxic brain injury. No patients required dialysis at discharge. Complications included 1 permanent stroke. All operative patients survived to hospital discharge. Average length of follow-up was 420 days, with 2 patient deaths at 76 and 230 days and 6 patients surviving over 1 year. CONCLUSIONS: ECMO can be used as a bridge to heart valve or septal defect surgery in severely decompensated patients. Through recovery of end-organ function, ECMO may allow surgical correction of structural heart disease in patients considered inoperable or convert a salvage situation to an elective operation.
引用
- Watkins AC, Maassel NL, Ghoreishi M, et al. Preoperative Venoarterial Extracorporeal Membrane Oxygenation Slashes Risk Score in Advanced Structural Heart Disease. Ann Thorac Surg. 2018. PMID: 30236527. doi:10.1016/j.athoracsur.2018.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。